@uccc-gorg.bsky.social
Reposted
#LobularBreastCancerAwarenessDay: New research from CU Cancer Center member Matthew Sikora, PhD, seeks ways to potentially open up a new treatment option for people with this challenging cancer type ⬇️
https://news.cuanschutz.edu/cancer-center/sikora-lobular-breast-cancer
https://news.cuanschutz.edu/cancer-center/sikora-lobular-breast-cancer
An Understudied Type of Breast Cancer Poses a Lurking Threat
Matt Sikora, PhD, seeks better answers for lobular breast cancer, which can be harder to detect & has lower survival rates after several years than other types.
news.cuanschutz.edu
October 15, 2025 at 3:47 PM
#LobularBreastCancerAwarenessDay: New research from CU Cancer Center member Matthew Sikora, PhD, seeks ways to potentially open up a new treatment option for people with this challenging cancer type ⬇️
https://news.cuanschutz.edu/cancer-center/sikora-lobular-breast-cancer
https://news.cuanschutz.edu/cancer-center/sikora-lobular-breast-cancer
Amazing research being done to understand and cure ILC breast cancer!! news.cuanschutz.edu/cancer-cente... @mjsikora.bsky.social
An Understudied Type of Breast Cancer Poses a Lurking Threat
Matt Sikora, PhD, seeks better answers for lobular breast cancer, which can be harder to detect & has lower survival rates after several years than other types.
news.cuanschutz.edu
October 15, 2025 at 5:39 PM
Amazing research being done to understand and cure ILC breast cancer!! news.cuanschutz.edu/cancer-cente... @mjsikora.bsky.social
Reposted
🔬Don’t miss Session 2 of our gynecologic cancer virtual series! Scott Lin, MD, PhD Candidate, will share insights on PARP inhibitors & ovarian cancer treatment. #OvarianCancer @uccc-gorg.bsky.social
📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
June 25, 2025 at 7:17 PM
🔬Don’t miss Session 2 of our gynecologic cancer virtual series! Scott Lin, MD, PhD Candidate, will share insights on PARP inhibitors & ovarian cancer treatment. #OvarianCancer @uccc-gorg.bsky.social
📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
Reposted
Dr. Kian Behbakht and AOA Dx CEO Oriana Papin-Zoghbi spoke with 360Dx about the urgent need for better ovarian cancer diagnostics, highlighting how vague symptoms delay care and the role of innovation and data in closing this critical diagnostic gap. #OvarianCancer
👏Full article: bit.ly/3ZMxqa3
👏Full article: bit.ly/3ZMxqa3
New Validation Data Shows Promise for AOA Dx Ovarian Cancer Early Detection Test
The firm presented data at AACR that showed the test had high accuracy when distinguishing ovarian cancer at early stages.
bit.ly
June 2, 2025 at 3:11 PM
Dr. Kian Behbakht and AOA Dx CEO Oriana Papin-Zoghbi spoke with 360Dx about the urgent need for better ovarian cancer diagnostics, highlighting how vague symptoms delay care and the role of innovation and data in closing this critical diagnostic gap. #OvarianCancer
👏Full article: bit.ly/3ZMxqa3
👏Full article: bit.ly/3ZMxqa3
Reposted
For Uterine Cancer Awareness Month, learn about the two primary types of uterine cancer and the symptoms to watch out for: bit.ly/45vieSg
June 2, 2025 at 4:35 PM
For Uterine Cancer Awareness Month, learn about the two primary types of uterine cancer and the symptoms to watch out for: bit.ly/45vieSg
Undermining Women’s Health Research — Gambling with the Public’s Health | New England Journal of Medicine www.nejm.org/doi/full/10....
Fight for Women’s Health! @cucancerbio.bsky.social
Fight for Women’s Health! @cucancerbio.bsky.social
Undermining Women’s Health Research — Gambling with the Public’s Health | NEJM
The benefits of women’s health research haven’t been limited to women. But actions by the Trump administration threaten to dismantle the hard-won progress in this area.
www.nejm.org
May 29, 2025 at 5:09 PM
Undermining Women’s Health Research — Gambling with the Public’s Health | New England Journal of Medicine www.nejm.org/doi/full/10....
Fight for Women’s Health! @cucancerbio.bsky.social
Fight for Women’s Health! @cucancerbio.bsky.social
Reposted
Insights on IHC testing for clinical decision making - put together by our talented Gyn Onc Path team! Shout to Dr. Rebecca Wolsky.
@cucancercenter.bsky.social
www.sciencedirect.com/science/arti...
@cucancercenter.bsky.social
www.sciencedirect.com/science/arti...
The evolving role of HER2 in gynecologic oncology and clinical trial design: A gynecologic pathologist's perspective
www.sciencedirect.com
May 24, 2025 at 8:04 PM
Insights on IHC testing for clinical decision making - put together by our talented Gyn Onc Path team! Shout to Dr. Rebecca Wolsky.
@cucancercenter.bsky.social
www.sciencedirect.com/science/arti...
@cucancercenter.bsky.social
www.sciencedirect.com/science/arti...
Reposted
New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab to Launch First-Of-Its-Kind $1M Global Grant to Improve Survival Rates ocrahope.org/news/new-glo...
New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab
Four leading ovarian cancer research charities from four countries are funding a new AI Accelerator Grant in partnership with Microsoft’s AI for Good Lab to supercharge the next cancer research breakt...
ocrahope.org
May 8, 2025 at 3:28 PM
New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab to Launch First-Of-Its-Kind $1M Global Grant to Improve Survival Rates ocrahope.org/news/new-glo...
Reposted
🔬Curious about gynecologic cancer research but not a science expert? Join CU DRS & CGCA’s new virtual, quarterly series making cutting-edge research easy to understand @uccc-gorg.bsky.social
📅 May 12 |🕛 12–1PM MST |💻 Virtual
Topic: Ovarian cancer early detection
Register today! loom.ly/7owjJ-g
📅 May 12 |🕛 12–1PM MST |💻 Virtual
Topic: Ovarian cancer early detection
Register today! loom.ly/7owjJ-g
April 22, 2025 at 8:15 PM
🔬Curious about gynecologic cancer research but not a science expert? Join CU DRS & CGCA’s new virtual, quarterly series making cutting-edge research easy to understand @uccc-gorg.bsky.social
📅 May 12 |🕛 12–1PM MST |💻 Virtual
Topic: Ovarian cancer early detection
Register today! loom.ly/7owjJ-g
📅 May 12 |🕛 12–1PM MST |💻 Virtual
Topic: Ovarian cancer early detection
Register today! loom.ly/7owjJ-g
MSTP retreat - Scott presenting his research findings on targeting the epigenetic environment of therapy resistant ovarian cancer. @cucancercenter.bsky.social @cugynonc.bsky.social
April 18, 2025 at 8:39 PM
MSTP retreat - Scott presenting his research findings on targeting the epigenetic environment of therapy resistant ovarian cancer. @cucancercenter.bsky.social @cugynonc.bsky.social
MSTP retreat - Raquel presenting her exciting research on Alt-EJ and PARP inhibitors. @cucancercenter.bsky.social @cugynonc.bsky.social
April 18, 2025 at 8:36 PM
MSTP retreat - Raquel presenting her exciting research on Alt-EJ and PARP inhibitors. @cucancercenter.bsky.social @cugynonc.bsky.social
Early detection for ovarian cancer. Drs. Helm and Behbakht published a study on symptom screening feasibility. www.sciencedirect.com/science/arti... @cucancercenter.bsky.social @cugynonc.bsky.social @powelldrescher.bsky.social @targetovarian.bsky.social
Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaire
Symptoms occur in up to 75% of patients with early-stage ovarian cancer; as such, using a symptom inventory (SI) to stratify which patients should rec…
www.sciencedirect.com
April 10, 2025 at 1:58 PM
Early detection for ovarian cancer. Drs. Helm and Behbakht published a study on symptom screening feasibility. www.sciencedirect.com/science/arti... @cucancercenter.bsky.social @cugynonc.bsky.social @powelldrescher.bsky.social @targetovarian.bsky.social
Reposted
Last month, Taylor Benson, PhD, showcased her work on identifying early biomarkers for ovarian clear cell carcinoma (OCCC) at STEM Poster Day, hosted by @projbridgeco.bsky.social!
#CancerResearch #CUAnschutz
Check out her poster: www.cuanschutz.edu/docs/librari...
#CancerResearch #CUAnschutz
Check out her poster: www.cuanschutz.edu/docs/librari...
www.cuanschutz.edu
April 8, 2025 at 4:29 PM
Last month, Taylor Benson, PhD, showcased her work on identifying early biomarkers for ovarian clear cell carcinoma (OCCC) at STEM Poster Day, hosted by @projbridgeco.bsky.social!
#CancerResearch #CUAnschutz
Check out her poster: www.cuanschutz.edu/docs/librari...
#CancerResearch #CUAnschutz
Check out her poster: www.cuanschutz.edu/docs/librari...
Reposted
A sad few days for the NIH, a tragedy for sure. Sad days for science, education, innovation in the US and, truly, globally. Wow
The gutting of NIH is something I never thought I’d witness in my lifetime. What a tragedy. What a senseless loss to the research community, to our ability to understand and treat diseases. What cruelty to deprive people of their livelihoods.
April 1, 2025 at 11:00 PM
A sad few days for the NIH, a tragedy for sure. Sad days for science, education, innovation in the US and, truly, globally. Wow
Early detection of ovarian cancer! www.cbsnews.com/colorado/new... @cugynonc.bsky.social @ocacademy.bsky.social
Women-founded company partners with CU Anschutz to develop, test first-of-its-kind ovarian cancer detection test
Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the cutting edge to detect and prevent ovarian cancer.
www.cbsnews.com
April 1, 2025 at 11:48 PM
Early detection of ovarian cancer! www.cbsnews.com/colorado/new... @cugynonc.bsky.social @ocacademy.bsky.social
Reposted
Dr. Davidson submitted a proposal to the Boettcher Foundation! Single-cell sequencing revealed that High-grade serous carcinoma subtypes are driven by microenvironment changes. She seeks to redefine HGSC subtypes & assess functional impacts on biomarkers w/ chemotherapy.🤞#HGSC #GynOnc #CUAnschutz
March 19, 2025 at 3:09 PM
Dr. Davidson submitted a proposal to the Boettcher Foundation! Single-cell sequencing revealed that High-grade serous carcinoma subtypes are driven by microenvironment changes. She seeks to redefine HGSC subtypes & assess functional impacts on biomarkers w/ chemotherapy.🤞#HGSC #GynOnc #CUAnschutz
At the Keystone Tumor Metabolism meeting! Just listened to an incredible presentation by @airdlab.bsky.social highlighting the intersection of p16/metabolism/immunology! Check out the BiorXiv pre-print www.biorxiv.org/content/10.1...
CDKN2ALow cancer cells outcompete macrophages for microenvironmental zinc to drive immunotherapy resistance
Approximately 50% of cancers exhibit decreased CDKN2A expression ( CDKN2A Low), which is linked to immune checkpoint blockade (ICB) resistance. While CDKN2A is traditionally recognized as a tumor supp...
www.biorxiv.org
March 18, 2025 at 12:06 AM
At the Keystone Tumor Metabolism meeting! Just listened to an incredible presentation by @airdlab.bsky.social highlighting the intersection of p16/metabolism/immunology! Check out the BiorXiv pre-print www.biorxiv.org/content/10.1...
Reposted
Annika rightfully points out that though this is positive, this is going to SERIOUSLY burden an NIH staff that is actively being further depleted.
Be nice to your SROs, POs, and GMSs, folks...
Be nice to your SROs, POs, and GMSs, folks...
Yay: Most postponed study sections have been rescheduled at this point.
Yikes: To do this, CSR has scheduled *289* study sections from 03/24-05/16/2025. For comparison, there were only 96 study sections from 3/24-5/17/2024. And NIH still plans to RIF more staff. docs.google.com/spreadsheets...
Yikes: To do this, CSR has scheduled *289* study sections from 03/24-05/16/2025. For comparison, there were only 96 study sections from 3/24-5/17/2024. And NIH still plans to RIF more staff. docs.google.com/spreadsheets...
2025 Study section tracking
docs.google.com
March 17, 2025 at 4:59 PM
Annika rightfully points out that though this is positive, this is going to SERIOUSLY burden an NIH staff that is actively being further depleted.
Be nice to your SROs, POs, and GMSs, folks...
Be nice to your SROs, POs, and GMSs, folks...
Reposted
There is SO MUCH RESEARCH that will simply NOT HAPPEN without these funds. We will be set back DECADES.
And for what? Greed. Hate. Spite.
I am crushed for the team at CDMRP that continues to support us, and for the work that will never be done.
And for what? Greed. Hate. Spite.
I am crushed for the team at CDMRP that continues to support us, and for the work that will never be done.
March 15, 2025 at 7:42 PM
There is SO MUCH RESEARCH that will simply NOT HAPPEN without these funds. We will be set back DECADES.
And for what? Greed. Hate. Spite.
I am crushed for the team at CDMRP that continues to support us, and for the work that will never be done.
And for what? Greed. Hate. Spite.
I am crushed for the team at CDMRP that continues to support us, and for the work that will never be done.
Today the @cugynonc.bsky.social hosted Dr. Lea to honor Carol Goldstein! Carol was passionate about ovarian cancer early detection and symptom screening! Dr. Lea discussing hereditary ovarian risk. @tinaswish.bsky.social
March 12, 2025 at 1:37 PM
Today the @cugynonc.bsky.social hosted Dr. Lea to honor Carol Goldstein! Carol was passionate about ovarian cancer early detection and symptom screening! Dr. Lea discussing hereditary ovarian risk. @tinaswish.bsky.social
Reposted
8 years ago @asbmb.bsky.social gave me +18 more trainees a crash course in advocacy for their DC Hill Day. With NIH slashing indirect costs effective immediately, university Govt Affairs teams will be swamped. Here's 10 tips for scientists contacting lawmakers +pics from Denver's 2017 Science March.
February 8, 2025 at 7:24 PM
8 years ago @asbmb.bsky.social gave me +18 more trainees a crash course in advocacy for their DC Hill Day. With NIH slashing indirect costs effective immediately, university Govt Affairs teams will be swamped. Here's 10 tips for scientists contacting lawmakers +pics from Denver's 2017 Science March.
Reposted
Eager to hear my Rep, @degette.house.gov , and @bennet.senate.gov, respond to these seismic cuts. This isn't cost cutting or trimming fat, it's destroying the foundation of research and medical infrastructure in this country. Heartened to see @murray.senate.gov's response.
This is what amounts to an ILLEGAL & indiscriminate funding cut for research centers everywhere. It will mean shuttering labs across the country, layoffs in red & blue states, and derailing lifesaving research on everything from cancer to opioid addiction.
We all need to speak out to save lives.
We all need to speak out to save lives.
February 8, 2025 at 4:15 AM
Eager to hear my Rep, @degette.house.gov , and @bennet.senate.gov, respond to these seismic cuts. This isn't cost cutting or trimming fat, it's destroying the foundation of research and medical infrastructure in this country. Heartened to see @murray.senate.gov's response.
Reposted
This is what amounts to an ILLEGAL & indiscriminate funding cut for research centers everywhere. It will mean shuttering labs across the country, layoffs in red & blue states, and derailing lifesaving research on everything from cancer to opioid addiction.
We all need to speak out to save lives.
We all need to speak out to save lives.
February 8, 2025 at 2:02 AM
This is what amounts to an ILLEGAL & indiscriminate funding cut for research centers everywhere. It will mean shuttering labs across the country, layoffs in red & blue states, and derailing lifesaving research on everything from cancer to opioid addiction.
We all need to speak out to save lives.
We all need to speak out to save lives.